Doosan Corporation Challenges Bio Market... First Participation in Korea's Largest Exhibition

[Asia Economy Reporter Moon Chaeseok] Doosan Corporation is participating in Korea's largest bio exhibition to showcase advanced material technology for pharmaceutical storage and is launching a full-scale market entry.

Doosan Corporation announced on the 11th that it will participate in "Bio Korea 2022," held for three days from the 11th to the 13th at COEX in Seoul. Now in its 17th year, "Bio Korea" is an event hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do, where global bio industry investors, executives, and researchers share the latest issues and advanced technologies in the biohealth market and seek business opportunities.

Doosan Corporation entered the bio business by investing $100 million in the U.S. company "SiO2 Materials Science" (hereafter SiO2) last December and securing exclusive business rights for the Asia-Oceania region. This marked Doosan's first entry into bio-related business, and the company announced plans to foster the pharmaceutical container business as a new growth engine going forward.

SiO2 possesses proprietary technology that deposits three layers (protective layer, barrier layer, adhesive layer) of glass-like components inside special plastic containers using plasma. Since each layer utilizes chemical reactions at the molecular level, precise bonding is possible, solving reactivity issues between the container and the medicine, thus combining the strengths of both glass and plastic.

At this exhibition, Doosan Corporation will introduce SiO2's technology and display product samples such as △Vials △Prefilled Syringes (PFS) △Blood Collection Tubes (BCT).

Vials are containers (medicine bottles) that hold liquid pharmaceuticals and vaccines. PFS refers to a method where medicine is prefilled in syringes, making it a highly convenient and high value-added product. BCTs are glass tube-type containers used to store collected blood.

Additionally, Doosan Corporation plans to demonstrate part of the production process using collaborative robots at the exhibition and will screen videos related to the process and technology at its booth.

A Doosan Corporation official stated, "Through this exhibition, we plan to showcase the advanced material products and related technologies for pharmaceutical storage that Doosan has secured and pursue business opportunities. We will focus all our capabilities to ensure that this business is established early as a new growth engine for Doosan."

Meanwhile, Doosan Corporation will also participate in the Korea-Australia Bio Innovation Forum held during the exhibition period to introduce advanced material products and related technologies for pharmaceutical storage.

This content was produced with the assistance of AI translation services.